TERAFAB: Tesla, SpaceX & xAI's $20–25B Chip Megafactory — What It Means for Leveraged Traders

Event Summary

According to Fortune and Manufacturing Dive, Tesla, SpaceX, and xAI jointly announced TERAFAB on March 21, 2026 — a $20–25 billion semiconductor manufacturing facility located at the North Campus of Giga Texas in Austin. The project targets 1 terawatt of annual computing output, producing two chip families: Tesla's AI5 chip (20% of output, for FSD/Cybercab/Optimus) and radiation-hardened space processors (80%, supporting SpaceX's planned one-million-satellite constellation). Small-batch production is targeted for late 2026, with volume production in 2027.

Important clarification: The original headline referencing Intel's participation is unverified. All confirmed sources identify only Tesla, SpaceX, and xAI as partners. Intel is NOT confirmed as a TERAFAB participant, and its foundry business may actually face competitive pressure from this initiative.

Noteably, Tesla's CFO confirmed the $20–25B TERAFAB investment is not yet incorporated into Tesla's existing 2026 capex plan, which already exceeds $20 billion.

Leverage Impact Analysis

TSLA is trading at $339.79 (down 2.83% on the day, 24h range: $339.54–$353.80), suggesting the market is digesting both the TERAFAB upside and near-term capex overhang concerns.

For leveraged traders on CoinUnited.io (up to 2000x on stock CFDs):

• -50x long TSLA CFD at $339.79: Each $1 move = ~$50 P&L per unit. With the 24h high at $353.80, a recovery to that level represents a +4.1% move — translating to a +205% return at 50x. Conversely, a stop below $339.54 (intraday low) triggers ~$0.25 adverse move, a -12.5% hit at 50x before broader downside.
• -High-leverage risk: The unconfirmed Intel headline adds headline-reversal risk. A correction to $320 from current levels represents a -5.8% move — enough to liquidate positions opened above $329 at 20x leverage.
• -Volatility note: The $20–25B capex surprise (not in guidance) creates binary near-term risk. Monitor Tesla's next earnings call for capex revision guidance before sizing high-leverage positions.

For ASML Holding N.V. and Applied Materials, Inc.: TERAFAB's massive fab construction implies significant semiconductor equipment procurement — a secondary bullish catalyst for these names as equipment suppliers.

Cross-Market Impact

Semiconductor sector — mixed signals: Taiwan Semiconductor Manufacturing Company Ltd. faces long-term foundry revenue risk as Musk noted existing capacity is "roughly 2% of the compute" his companies need. NVIDIA Corporation faces indirect AI chip competition longer-term, though TERAFAB's 2027+ timeline limits immediate pressure. Lam Research Corporation and ASML stand to benefit from fab equipment orders.

Indices: The US100 and US500 face mixed signals — bullish AI infrastructure capex cycle narrative vs. concern over concentrated Musk-entity risk and Tesla balance sheet stretch. Per the 2026 Stocks Market Outlook, AI capex remains a dominant tech sector driver, and TERAFAB reinforces that theme.

Macro: The project is domestically sited (Austin, TX), carrying potential policy tailwind under current US semiconductor reshoring incentives.

Trading Considerations

TSLA's key near-term levels: intraday support at $339.54, resistance at the 24h high of $353.80. The unresolved capex guidance gap ($20–25B not in 2026 plan) is a material overhang — watch for analyst revisions and any Tesla investor day commentary. Tom's Hardware notes full-scale advanced node manufacturing may not be realistic until the 2030s, tempering short-term euphoria.

For equipment names (ASML, Applied Materials), TERAFAB construction timelines suggest order flow catalysts in 2026–2027 — a medium-term bullish signal worth monitoring on pullbacks.

Trade Tesla, Inc. on CoinUnited.io

Trade TSLA with up to 1000xx leverage → | Create Free Account